BioSpace News Archive

Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), announced today that Alex Ovadia, Chief Executive Officer, will provide a corporate overview at the H.C. Wainwright 21st Annual Global Investment Conference, being held September 8-10, 2019 in New York.

Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications.

The Health & Safety Institute Announces Sale to Waud Capital Partners

Ensysce Biosciences, Inc., a clinical stage drug delivery company, focusing on reducing deaths from opioid use, today announced that D. Lynn Kirkpatrick, Ph.D., Chief Executive Officer, will present at the Janney Healthcare Conference 2019 in New York on Monday September 9,

Satsuma Pharmaceuticals, Inc. announced that it will be presenting two posters at the 19th Congress of the International Headache Society convening at the Convention Centre Dublin in Dublin, Ireland from the 5th to the 8th of September 2019.

Lineage Cell Therapeutics, Inc. announced that its paper entitled “Transplantation of Human Embryonic Stem Cell Derived Retinal Tissue in the Subretinal Space of the Cat Eye,” (Singh et al.), has been selected for publishing and will be featured on the cover of the September 2019 issue of Stem Cells and Development Journal, Volume 28, Number 17.

Bayer announced Marianne De Backer PhD as the new Head of Business Development & Licensing of its Pharmaceuticals Division.

Morgan Stanley 17th Annual Global Healthcare Conference in New York on Tuesday, September 10, 2019 at 2:55 p.m. Eastern Time.

Activities Reflect Company’s 24-Year, $136-plus Million Commitment to Childhood Cancer Initiatives

Neovasc, Inc. announced that its Neovasc Reducer™ (the “Reducer”) for the treatment of patients suffering from refractory angina has been added to the European Society of Cardiology (ESC) Practice Guidelines.